Drugs / AX-024.HCl
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02546635 | Aug → Dec 2015 | — | Artax Biopharma Inc | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AX-024.HCl | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02546635 ↗ |
| Route | Oral | “single oral dose of 500 mg AX-024.HCl under fasted and fed states” NCT02546635 ↗ |